MGN-1374

N/A

Report date: 2024/02/21 17:01:14
NME

Base Information

Drug NameMGN-1374
Drug Alias NameMGN-1374
ClassificationSmall molecules
Mechanisms of ActionmicroRNA-15 inhibitorsmicroRNA-155 inhibitors
TargetsmicroRNA-15microRNA-155
Therapy Area/IndicationsPostmyocardial Infarction Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesViridian Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesViridian Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsPostmyocardial Infarction Syndrome

Other Information

ATC CodeN/A
Related LinksN/A